New drug approved for age related macular degenerationBMJ 2007; 335 doi: https://doi.org/10.1136/bmj.39324.649919.AD (Published 11 October 2007) Cite this as: BMJ 2007;335:746
Three randomised controlled trials of ranibizumab and two of pegaptanib, involving 1511 patients with age related macular degeneration, have shown that both drugs are beneficial. Patients receiving …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial